POST Online Media Lite Edition



 

Tekmira appoints Richard Henriques to board

Staff writer |
Vancouver, BC, Canada - December 22, 2014, Vancouver, BC, Canada - Tekmira Pharmaceuticals Corporation, a developer of RNA interference (RNAi) therapeutics, appoints Richard C. Henriques, Jr. to the company's board of directors.

Article continues below






Mr. Henriques will also be a member of the Audit Committee. Mr. Henriques recently served as Chief Financial Officer for the Bill & Melinda Gates Foundation. Mr. Henriques's previous experience includes more than 25 years with Merck & Co. Inc.

During this time, he held several executive leadership positions in Finance for the Global Human Health Division and other Global Operations in the United States, Canada, Latin America, Europe, the Middle East, Africa, Japan, Australia and New Zealand.

Mr. Henriques holds a BA in Oriental Studies from the University of Pennsylvania, and an MBA with a concentration in Finance from the Wharton School of Business.

 LATEST MOVES FROM British Columbia 

Pacific Empire Minerals appoints Samantha Shorter to board
Dorian L. Nicol jons Mountain Boy Minerals board
Permex Petroleum appoints two to board
Ritchie Bros. CFO Sharon Driscoll to retire
Golcap Resources appoints Monty Sutton as director

What to read next

Ian C. Mortimer joins Xenon as CFO
Timothy Ruane new chief executive officer of InSite Vision
PhaseRx appoints Peggy Phillips to board of directors